Advertisement
Advertisement

ANIK

ANIK logo

Anika Therapeutics Inc

14.00
USD
+0.53
+3.96%
Apr 17, 15:59 UTC -4
Closed
exchange

After-Market

14.02

+0.01
+0.09%

Anika Therapeutics Inc Profile

About

Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative pain management to regenerative cartilage repair. Anika's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration.

Info & Links

CEO

Cheryl R. Blanchard

Headquarters

32 WIGGINS AVENUE
BEDFORD, MA 01730, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.anika.com

Auditor

Deloitte & Touche LLP

Share holders

101

Employees

288

Anika Therapeutics Inc Statistics

Valuation Measures

Market Capitalization2

207.82M

Enterprise Value

152.19M

Enterprise Value/EBITDA(ttm)

50.39

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

1.57

Price to Book(mrq)

1.44

Price to Cash(ytd)

3.59

Profitability

Gross Margin(ttm)

-404.86%

Operating Margin(ttm)

-2.74%

Profit Margin(ttm)

401.60%

Return on Equity(ttm)

-2.22%

Return on Invested Capital(ttm)

-2.16%

Return on Assets(ttm)

-1.75%

Income Statement

Revenue(ttm)

119.91M

Revenue Per Share(ttm)

8.46

Gross Profit(ttm)

76.00M

EBITDA(ttm)3

3.02M

Net Income Available to Common(ttm)

-56.39M

Diluted EPS(ttm)

-6.65

Share Statistics

Beta (5Y Monthly)

0.89

52-Week Change

-44.94%

S&P 500 52-Week Change

5.43%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

14.18M

Dividend Yield

0.00%

Float4

13.49M

% Held by Insiders

7.86%

% Held by Institutions

91.53%

Balance Sheet

Total Cash(mrq)

55.63M

Total Cash Per Share(mrq)

3.92

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.88%

Quick Ratio(mrq)

3.78%

Book Value Per Share(mrq)

10.68

Cash Flow

Operating Cash Flow Per Share(ytd)

0.37

Free Cash Flow(ytd)

-2.33M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement